Press Releases

Delayed 55s

Fastest customizable press release feed in the world.

Signed out · Sign up for real-time

Updates arrive automatically.

  • Holland America Line's 2028-2029 Asia Cruise Season Blooms with Cherry Blossoms and Five New Ports
    PR·

    Holland America Line's 2028-2029 Asia Cruise Season Blooms with Cherry Blossoms and Five New Ports

    Eurodam's first Asia season features new destinations, more time ashore and opportunities to experience Japan during its famed cherry blossom seasonKey Takeaways: Eurodam makes its Asia debut with five new ports, expanding Holland America Line's 2028-2029 season across Japan, South Korea, China, Taiwan, the Philippines and Southeast Asia. More time ashore and Japan's cherry blossom season deepen the destination experience, with overnight stays and late-night departures across 14 ports, plus spring sailings timed to give guests opportunities to see the famed blooms. A new 27-day Coffee, Tea & Spice Route Legendary Voyage expands longer exploration of the region, visiting 13 ports across seven c

  • Nano Labs Announces Postponement of 2026 Annual General Meeting
    PR·

    Nano Labs Announces Postponement of 2026 Annual General Meeting

    Nano Labs Ltd ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider, and a crypto treasury company, today announced that its 2026 annual general meeting of shareholders (the "2026 Annual Meeting"), originally scheduled to be held at 10:00 A.M. on November 24, 2026, Beijing time (9:00 P.M. on November 23, 2026, U.S. Eastern time), has been postponed and will now be held at 10:00 A.M. on December 17, 2026, Beijing time (9:00 P.M. on December 16, 2026, U.S. Eastern time) (the "Postponed Annual Meeting"). The Postponed Annual Meeting will be held at the same venue as originally scheduled, being 12F, Ch

  • RLX Technology Announces Unaudited Third Quarter 2026 Financial Results
    PR·

    RLX Technology Announces Unaudited Third Quarter 2026 Financial Results

    RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial HighlightsNet revenues were RMB1,916.6 million (US$285.9 million) in the third quarter of 2026, increasing by 69.7% from RMB1,129.3 million in the same period of 2025. Gross profit increased by 26.7% to RMB446.6 million (US$66.6 million) in the third quarter of 2026. Gross margin was 23.3% in the third quarter of 2026, compared with 31.2% in the same period of 2025, primarily due to a change in the revenue mix follow

  • Equinor ASA: Announcement of cash dividend of NOK 3.7448 per share for second quarter 2026
    PR·

    Equinor ASA: Announcement of cash dividend of NOK 3.7448 per share for second quarter 2026

    Equinor ASA ((OSE: EQNR, NYSE:EQNR) announced on 22 July 2026 a cash dividend per share of USD 0.39 for second quarter 2026. The NOK cash dividend per share is based on average USDNOK fixing rate from Norges Bank in the period plus/minus three business days from record date 16 November 2026, in total seven business days. Average Norges Bank fixing rate for this period was 9.6021. Total cash dividend for second quarter 2026 is consequently NOK 3.7448 per share. On 25 November 2026, the cash dividend will be paid to relevant shareholders on Oslo Børs (Oslo Stock Exchange) and to holders of American Depositary Receipts ("ADRs") on the New York Stock Exchange. This information is published in

  • ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026
    PR·

    ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026

    Geneva, Switzerland, November 20, 2026 - Addex Therapeutics (SIX and NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its 2026 Third Quarter Financial Results on November 25, 2026. Tim Dyer, CEO, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CET (15:00 GMT / 10:00 EDT / 07:00 PDT) on November 25, 2026. Title: Addex Therapeutics Reports 2026 Third Quarter financial results and Provides Corporate UpdateDate: November 25, 2026Time: 16:00 C

  • Okeanis Eco Tankers Corp. – Ex Dividend Date
    PR·

    Okeanis Eco Tankers Corp. – Ex Dividend Date

    Reference is made to the key information relating to Q3 2026 dividend announced by Okeanis Eco Tankers Corp. ("OET" or the "Company") (NYSE:ECO) on November 11, 2026. The Company's common shares will be traded ex dividend USD 7.00 per common share on the Oslo Stock Exchange from today, November 20, 2026 and on the New York Stock Exchange from November 23, 2026. Contacts Company:Iraklis Sbarounis, CFOTel: +30 210 480 4200ir@okeanisecotankers.com Investor Relations / Media Contact:Nicolas Bornozis, PresidentCapital Link, Inc.230 Park Avenue, Suite 1540, New York, N.Y. 10169Tel: +1 (212) 661-7566okeanisecotankers@capitallink.com About OETO

  • Moomoo steps up Australian expansion with Sydney Roosters deal, second retail store
    PR·

    Moomoo steps up Australian expansion with Sydney Roosters deal, second retail store

    Moomoo Australia and New Zealand today announced its largest local brand investment to date, signing on as platinum partner and official share-trading platform of the Sydney Roosters from the 2027 NRL season. The deal coincides with the opening of Moomoo's second retail store, in Melbourne's eastern hub of Box Hill, marking one year since the brokerage opened its first physical site in Chatswood, Sydney. Together, the moves cap four years of rapid local growth, signalling a broader push into mainstream retail and high-net-worth investing. Named Australia's most-trusted investing app in Finder's 2026 customer satisfaction awards, moomoo has also h

  • Neugebauer: Texas Court Ruling on Fermi's 70/30 Boardroom Maneuver Is a Loss for 100% of Texas Shareholders
    PR·

    Neugebauer: Texas Court Ruling on Fermi's 70/30 Boardroom Maneuver Is a Loss for 100% of Texas Shareholders

    Neugebauer: Under this ruling, the board can entrench itself with one quick vote, while shareholders need 70% of all outstanding shares to fight back. Neugebauer: "That isn't Texas-style good governance. It's entrenchment."Directors who failed to win a majority on October 30 are still sitting in the boardroom. Neugebauer filing appeal because Texas's standing as the best place to do business in America depends on getting this right. Texan voters have made it clear that they don't accept that people in power can do whatever they want and change the rules whenever it suits them.

  • Yesway Announces Pricing of Secondary Public Offering
    PR·

    Yesway Announces Pricing of Secondary Public Offering

    Yesway, Inc. (NASDAQ:YSWY) ("Yesway") today announced the pricing of the underwritten secondary offering of 5,000,000 shares of Yesway’s Class A common stock by certain of its existing stockholders at a price to the public of $19.00 per share. In addition, the underwriters of the offering have a 30-day option to purchase from the selling stockholders up to 750,000 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The selling stockholders will receive all of the net proceeds from this offering. The offering is expected to close on November 23, 2026, subject to customary cl

  • FF EAI Robotics Ecosystem (FFR) Appoints Carolyn Kissane as Independent Director, Joining Jason E. Dodier and other Board Members to Bring Critical Expertise to Advance Physical AI Education, Industry Partnerships and Scalable Commercialization
    PR·

    FF EAI Robotics Ecosystem (FFR) Appoints Carolyn Kissane as Independent Director, Joining Jason E. Dodier and other Board Members to Bring Critical Expertise to Advance Physical AI Education, Industry Partnerships and Scalable Commercialization

    Carolyn Kissane, Associate Dean of NYU's Center for Global Affairs, brings expertise in higher education and academic-industry collaboration to help advance FFR's robotics education ecosystem, talent development, and developer engagement. Independent Director Jason E. Dodier brings critical expertise in commercial development, capital formation, infrastructure, and operations to support industry partnerships and scalable commercialization, reinforcing FFR's positioning as the first U.S.-listed pure-play "Four-Core Full-Stack AI" humanoid and bionic

  • Boston Scientific announces pricing of $3.0 billion and €4.25 billion offerings of senior notes
    PR·

    Boston Scientific announces pricing of $3.0 billion and €4.25 billion offerings of senior notes

    Boston Scientific Corporation (the "Company") (NYSE:BSX) announced today that it has priced a public offering of $3,000,000,000 aggregate principal amount of U.S. dollar-denominated notes (the "USD Offering"), consisting of $1,000,000,000 aggregate principal amount of 5.375% Senior Notes due 2029, $750,000,000 aggregate principal amount of 5.500% Senior Notes due 2031, $750,000,000 aggregate principal amount of 5.750% Senior Notes due 2033 and $500,000,000 aggregate principal amount of 5.875% Senior Notes due 2036 (collectively, the "USD Notes"). In addition, the Company announc

  • IT Tech Packaging, Inc. Announces Receipt of Going Concern Opinion from Its Independent Registered Public Accounting Firm
    PR·

    IT Tech Packaging, Inc. Announces Receipt of Going Concern Opinion from Its Independent Registered Public Accounting Firm

    IT Tech Packaging, Inc. (NYSE:ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced that on November 19, 2026, it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Form 10-K") with the U.S. Securities and Exchange Commission. The audited consolidated financial statements included in the Form 10-K contain an audit report from the Company's independent registered public accounting firm, Audit Alliance LLP, that includes an explanatory paragraph titled "Material Uncertainty Related to Going Concern." The paragraph states t

  • CVR Energy Announces Pricing of $1.25 Billion of 9.250% Senior Secured Notes Due 2032
    PR·

    CVR Energy Announces Pricing of $1.25 Billion of 9.250% Senior Secured Notes Due 2032

    CVR Energy, Inc. (the "Company" or "CVR Energy") (NYSE:CVI) announced today the pricing of its previously announced private placement (the "Offering") pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"), of $1.25 billion in aggregate principal amount of 9.250% senior secured notes due 2032 (the "Notes"). The Notes will be issued at a price equal to 98.980% of their principal amount. The Notes will mature on March 15, 2032. The Offering is expected to close on November 25, 2026, subject to customary closing conditions. Prior to the closing of the Acquisition (as defined below), the Notes will not be guaranteed and will be secured only by

  • BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer
    PR·

    BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer

    BlackRock Health Sciences Term Trust (the "Fund") announced today the final results of its tender offer ("Tender Offer") for up to 5% of its outstanding common shares (the "Shares"). The Tender Offer, which expired at 5:00 p.m. Eastern time on November 18, 2026, was oversubscribed. Therefore, in accordance with the terms and conditions of the Tender Offer, the Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered ("Pro-Ration Factor"). The final results of the Tender Offer are provided in the table below. Fund Name Ticker CUSIP Number of Shares Tendered

  • Avnet Declares Regular Quarterly Dividend
    PR·

    Avnet Declares Regular Quarterly Dividend

    Avnet, Inc. (Nasdaq: AVT), a leading global technology distributor and solutions provider, announced that its Board of Directors has approved a regular quarterly cash dividend of $0.37 per share. The dividend will be paid on December 16, 2026, to shareholders of record as of the close of business on December 2, 2026. About AvnetAs a leading global technology distributor and solutions provider, Avnet has served customers’ evolving needs for more than a century. Through regional and specialized businesses around the world, we support customers and suppliers at every stage of the product lifecycle. We help companies adapt to change and accelerate the design and supply stages of product developme

  • Blue Moon Completes its Acquisition of the Turner Copper-Gold VMS Deposit
    PR·

    Blue Moon Completes its Acquisition of the Turner Copper-Gold VMS Deposit

    Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV:MOON) (NASDAQ:BMM) is pleased to announce that, further to its news release dated September 23, 2026, the Company has completed its acquisition (the "Transaction") of the Turner Copper-Gold ("Turner") deposit located in O'Brien, Oregon from Gold Coast Mining Inc. ("Gold Coast"), pursuant to the terms of a definitive agreement entered into between the parties, effective September 23, 2026 (the "Definitive Agreement"). Turner is a past producing volcanic massive sulphide deposit located near the border between Oregon and California, with a similar deposit type and associated metals to the Company's Blue

  • Mesoblast Wins Deloitte Tech Fast 50 Leadership & Enterprise Growth Award
    PR·

    Mesoblast Wins Deloitte Tech Fast 50 Leadership & Enterprise Growth Award

    Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has received the Leadership & Enterprise Growth Award at the Deloitte Technology Fast 50 Australia Awards which recognizes Australia’s fastest-growing technology companies and the founders, innovators and leaders shaping the future of the sector. The award recognizes Mesoblast’s successful evolution to a commercial-stage biotechnology company following its U.S. launch of Ryoncil® (remestemcel-L-rknd), the first mesenchymal stromal cell therapy approved by the U.S. Food and Drug Administration (FDA).1 "We ar